These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 25866969)

  • 1. Pharmacological HIF2α inhibition improves VHL disease-associated phenotypes in zebrafish model.
    Metelo AM; Noonan HR; Li X; Jin Y; Baker R; Kamentsky L; Zhang Y; van Rooijen E; Shin J; Carpenter AE; Yeh JR; Peterson RT; Iliopoulos O
    J Clin Invest; 2015 May; 125(5):1987-97. PubMed ID: 25866969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zebrafish mutants in the von Hippel-Lindau tumor suppressor display a hypoxic response and recapitulate key aspects of Chuvash polycythemia.
    van Rooijen E; Voest EE; Logister I; Korving J; Schwerte T; Schulte-Merker S; Giles RH; van Eeden FJ
    Blood; 2009 Jun; 113(25):6449-60. PubMed ID: 19304954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A zebrafish model for VHL and hypoxia signaling.
    van Rooijen E; Santhakumar K; Logister I; Voest E; Schulte-Merker S; Giles R; van Eeden F
    Methods Cell Biol; 2011; 105():163-90. PubMed ID: 21951530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. von Hippel-Lindau tumor suppressor mutants faithfully model pathological hypoxia-driven angiogenesis and vascular retinopathies in zebrafish.
    van Rooijen E; Voest EE; Logister I; Bussmann J; Korving J; van Eeden FJ; Giles RH; Schulte-Merker S
    Dis Model Mech; 2010; 3(5-6):343-53. PubMed ID: 20335444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of vhl in the zebrafish pronephros recapitulates early stages of human clear cell renal cell carcinoma.
    Noonan HR; Metelo AM; Kamei CN; Peterson RT; Drummond IA; Iliopoulos O
    Dis Model Mech; 2016 Aug; 9(8):873-84. PubMed ID: 27491085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological restoration of visual function in a zebrafish model of von-Hippel Lindau disease.
    Ward R; Ali Z; Slater K; Reynolds AL; Jensen LD; Kennedy BN
    Dev Biol; 2020 Jan; 457(2):226-234. PubMed ID: 30825427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
    Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. von Hippel-Lindau gene plays a role during zebrafish pronephros development.
    Chen YH; Chang CF; Lai YY; Sun CY; Ding YJ; Tsai JN
    In Vitro Cell Dev Biol Anim; 2015 Nov; 51(10):1023-32. PubMed ID: 26194803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zebrafish as a model for von Hippel Lindau and hypoxia-inducible factor signaling.
    Kim HR; Greenald D; Vettori A; Markham E; Santhakumar K; Argenton F; van Eeden F
    Methods Cell Biol; 2017; 138():497-523. PubMed ID: 28129856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo models analyzing von Hippel-Lindau disease-specific mutations.
    Rathmell WK; Hickey MM; Bezman NA; Chmielecki CA; Carraway NC; Simon MC
    Cancer Res; 2004 Dec; 64(23):8595-603. PubMed ID: 15574766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.
    Jensen RL; Gillespie D; House P; Layfield L; Shelton C
    J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dicer suppresses the malignant phenotype in VHL-deficient clear cell renal cell carcinoma by inhibiting HIF-2α.
    Fan Y; Li H; Ma X; Gao Y; Bao X; Du Q; Ma M; Liu K; Yao Y; Huang Q; Zhang Y; Zhang X
    Oncotarget; 2016 Apr; 7(14):18280-94. PubMed ID: 26943772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of von Hippel-Lindau protein synergizes with doxorubicin to suppress hepatocellular carcinoma in mice.
    Wang J; Ma Y; Jiang H; Zhu H; Liu L; Sun B; Pan S; Krissansen GW; Sun X
    J Hepatol; 2011 Aug; 55(2):359-68. PubMed ID: 21168458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF alpha expression in VHL-deficient renal cancer cells is dependent on phospholipase D.
    Toschi A; Edelstein J; Rockwell P; Ohh M; Foster DA
    Oncogene; 2008 Apr; 27(19):2746-53. PubMed ID: 17998935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic VHL gene functions and the VHL disease.
    Bader HL; Hsu T
    FEBS Lett; 2012 Jun; 586(11):1562-9. PubMed ID: 22673568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The VHL Tumor Suppressor Gene: Insights into Oxygen Sensing and Cancer.
    Kaelin WG
    Trans Am Clin Climatol Assoc; 2017; 128():298-307. PubMed ID: 28790514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
    Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
    Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.
    Maxwell PH; Wiesener MS; Chang GW; Clifford SC; Vaux EC; Cockman ME; Wykoff CC; Pugh CW; Maher ER; Ratcliffe PJ
    Nature; 1999 May; 399(6733):271-5. PubMed ID: 10353251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nervous system involvement in von Hippel-Lindau disease: pathology and mechanisms.
    Vortmeyer AO; Falke EA; Gläsker S; Li J; Oldfield EH
    Acta Neuropathol; 2013 Mar; 125(3):333-50. PubMed ID: 23400300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2 alpha in von Hippel-Lindau renal cell carcinoma.
    Petrella BL; Lohi J; Brinckerhoff CE
    Oncogene; 2005 Feb; 24(6):1043-52. PubMed ID: 15592504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.